Trial · NCT01140451
Results by group146
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 146
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren/Ataluren | At least 1 TEAE | 100 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Placebo/Ataluren | At least 1 TEAE | 97.9 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren/Ataluren | Grade 1 TEAE | 14.7 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Placebo/Ataluren | Grade 1 TEAE | 18.8 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren/Ataluren | Grade 2 TEAE | 62.1 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Placebo/Ataluren | Grade 2 TEAE | 51.0 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren/Ataluren | Grade 3 TEAE | 23.2 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Placebo/Ataluren | Grade 3 TEAE | 26.0 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren/Ataluren | Grade 4 TEAE | 0 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Placebo/Ataluren | Grade 4 TEAE | 1.0 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren/Ataluren | Grade 5 TEAE | 0 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Placebo/Ataluren | Grade 5 TEAE | 1.0 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren/Ataluren | Unrelated TEAE | 29.5 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Placebo/Ataluren | Unrelated TEAE | 26.0 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren/Ataluren | Unlikely related TEAE | 37.9 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Placebo/Ataluren | Unlikely related TEAE | 33.3 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren/Ataluren | Possibly related TEAE | 28.4 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Placebo/Ataluren | Possibly related TEAE | 31.3 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren/Ataluren | Probably related TEAE | 4.2 | percent of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) | Placebo/Ataluren | Probably related TEAE | 7.3 | percent of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01140451/results